My research efforts have been focused on identifying prognostic and therapeutic biomarkers in B-cell lymphoma. My research interests also include investigation of molecular and immune mechanisms underlying the poor clinical outcomes of lymphoma, the pathogenesis and evolution of drug resistant clones, and development of novel therapies for aggressive B-cell lymphoma.

Current Research Interests
The p53 pathway in lymphoma
High-grade B-cell lymphomas with double-hit cytogenetics and the MYC biology
Immunosuppressive mechanisms in lymphomas and determinants shaping the immune response in the tumor microenvironment
Genetic and epigenetic profiling
Therapeutic strategies for the refractory/relapsed lymphoma
New tools for diagnosis, risk prediction, and therapeutic selection in lymphoma.